Convergence Institute of Biomedical Engineering and Biomaterials, Seoul National University of Science and Technology, Seoul, 01811, Republic of Korea.
Department of Biomedical Engineering, Daelim University, Anyang, 13916, Republic of Korea.
J Nanosci Nanotechnol. 2021 Jul 1;21(7):3735-3741. doi: 10.1166/jnn.2021.19168.
Nifedipine (NF)-loaded poly(lactic acid) (PLA) and PLA/polyethylene glycol (PLA/PEG) microcapsules are synthesized using a high-speed agitator and a syringe pump with an oil-in-water emulsion-solvent evaporation technique to evaluate the effect of PLA/PEG ratio on morphology and drug release behavior of the capsules. Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimeter (DSC), and X-ray diffraction (XRD) results indicate that PEG reacts successfully with PLA due to the ether bond between PEG and PLA. The drug release rate of PLA and PLA/PEG capsules increases dramatically from 0 to 5 min and then reaches a plateau within 15 to 20 min. Due to the high specific surface area, the amount of NF released is raised by reducing the PLA concentration from 5 wt% to 2 wt%. Unlike PLA capsules, the drug release rate of PLA/PEG capsules increases due to the size effect by varying the PLA/PEG ratio from 10/0 to 6/4. Larger PLA/PEG capsules are attributed to higher amounts of encapsulated NF. The capsules show no evidence of cytotoxicity, suggesting that the PLA and PLA/PEG drug carriers are clinically safe.
硝苯地平(NF)负载的聚乳酸(PLA)和 PLA/聚乙二醇(PLA/PEG)微胶囊是使用高速搅拌器和注射器泵通过油包水乳液-溶剂蒸发技术合成的,以评估 PLA/PEG 比例对胶囊形态和药物释放行为的影响。傅里叶变换红外光谱(FT-IR)、差示扫描量热法(DSC)和 X 射线衍射(XRD)结果表明,由于 PEG 和 PLA 之间的醚键,PEG 与 PLA 成功反应。PLA 和 PLA/PEG 胶囊的药物释放率从 0 到 5 分钟急剧增加,然后在 15 到 20 分钟内达到平台期。由于比表面积高,通过将 PLA 浓度从 5wt%降低至 2wt%,NF 的释放量增加。与 PLA 胶囊不同,通过改变 PLA/PEG 比例从 10/0 至 6/4,PLA/PEG 胶囊的药物释放率因尺寸效应而增加。较大的 PLA/PEG 胶囊归因于包裹的 NF 量较高。这些胶囊没有显示出细胞毒性的证据,表明 PLA 和 PLA/PEG 药物载体在临床上是安全的。